​

Funding Round

Series A - IMIDomics

Series A - IMIDomics

Investment Firm

Overview

IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).

Announced Date

Jul 27, 2021

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

DNS Capital

DNS Capital

DNS Capital is a early_stage_venture and late_stage_venture and venture firm.

Participant Investors

4

Investor Name
Participant InvestorTao Capital Partners
Participant InvestorDNS Capital
Participant InvestorThe Pritzker Organization
Participant InvestorBristol-Myers Squibb

Round Details and Background

IMIDomics raised $16500000 on 2021-07-27 in Series A

IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 27, 2021
Series A - IMIDomics
4-16.5M
Feb 15, 2022
Corporate Round - IMIDomics
1-undefined
Mar 04, 2024
Corporate Round - IMIDomics
1-undefined

Recent Activity

There is no recent news or activity for this profile.